News | Peripheral Artery Disease (PAD) | August 01, 2019

Endovascular-first Approach Equal to Open Surgery in Avoiding Amputation for Critical Limb Ischemia

Patients who underwent a less-invasive procedure to open clogged leg arteries were just as likely to survive with their legs intact as patients who had more invasive surgery

Endovascular-first Approach Equal to Open Surgery in Avoiding Amputation for Critical Limb Ischemia

August 1, 2019 — Less-invasive procedures to open severely clogged leg arteries were as good at helping people survive and avoid amputation as more invasive open surgeries, according to a new study. The results were reported in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

The most severe form of clogged leg arteries, critical limb ischemia may result in slow healing leg wounds, gangrene or the need for amputation.  The study notes that the incidence of critical limb ischemia has continued to rise with the aging U.S. population. By the year 2050 it is estimated the number of patients who undergo amputation will more than double from 1.6 million to 3.6 million.

“The question has been whether to first offer an open surgery or an endovascular procedure to patients with critical limb ischemia. Each strategy has its benefits, but it is unclear which one first is optimal and we wanted to gain a better understanding of what the current outcomes were,” said Jonathan Lin, M.D., a surgery resident in the department of surgery at UC Davis Health.

In an open surgery, a section of vein from the patient (or a synthetic material if there is no appropriate vein available) is used to bypass the blockage and provide an alternative route for the blood to reach the lower leg and foot. In a less invasive endovascular procedure, the physician gains access to the inside of the artery with a thin, flexible tube and wire that is inserted through a small incision in the groin and guided to the blocked area. After the clogged area is opened, it can be supported and propped open by inserting a medicine-coated wire mesh tube, or stent.

Open procedures require a hospital stay and about a month of recovery. Endovascular procedures can be done on an outpatient basis and may be performed on patients who are not healthy enough for open surgery.

Investigators examined records of more than 16,000 patients (59 percent male, average age 71 years). Patients had undergone either open bypass first (36 percent) or an endovascular procedure first (64 percent) for critical limb ischemia at non-government hospitals in California between 2005 and 2013.

Compared with patients who received open surgery first, researchers found that, during the study period, those who were first treated with an endovascular procedure had a longer period of amputation-free survival and were:

  • Less likely to require a major amputation, below or above the knee, during the study;
  • However slightly more likely to require another procedure or surgery to restore blood flow; and
  • No more likely to die, although at the time of their procedures many had serious medical conditions such as kidney failure, congestive heart failure and diabetes.

“The data here suggest that, in the grand scheme of things, an endovascular-first approach is at least not producing a worse result,” Lin said. “Regardless, the type of therapy a patient will receive needs to be a decision that patients and their physicians arrive at together. Critical limb ischemia is usually not an emergency and there is time to determine the most appropriate course of therapy. “

The study was limited by not having information on medical factors (such as the severity of their wounds and whether they had a long and wide enough vein to perform a bypass) that might have influenced whether patients were treated with open surgery or an endovascular procedure. The patient population was also limited to specific hospitals in California.

Co-authors are Ann Brunson, M.S.; Patrick S. Romano, M.D., MPH; Matthew W. Mell, M.D., MS; and Misty Humphries, M.D., MAS. Author disclosures are on the manuscript.

The National Center for Advancing Translational Sciences, National Institutes of Health, funded the study.

For more information: www.ahajournals.org/journal/circoutcomes

 

Reference

Lin J.H., Brunson A., Romano P.S., et al. Endovascular-First Treatment Is Associated With Improved Amputation-Free Survival in Patients With Critical Limb Ischemia. Circulation: Cardiovascular Quality and Outcomes, published online July 30, 2019. https://doi.org/10.1161/CIRCOUTCOMES.118.005273

Related Content

FDA Issues Final Guidance on Live Case Presentations During IDE Clinical Trials
News | Cardiovascular Clinical Studies | July 10, 2019
The U.S. Food and Drug Administration (FDA) issued the final guidance “Live Case Presentations During Investigational...
Veradigm Partners With American College of Cardiology on Next-generation Research Registries
News | Cardiovascular Clinical Studies | July 03, 2019
The American College of Cardiology (ACC) has partnered with Veradigm, an Allscripts business unit, to power the next...
New FDA Proposed Rule Alters Informed Consent for Clinical Studies
News | Cardiovascular Clinical Studies | November 19, 2018
The U.S. Food and Drug Administration (FDA) is proposing to add an exception to informed consent requirements for...
A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
Overlay Init